Home » today » Health » “FDA” recommends the withdrawal of ranitidine products from the market, chiefly Zantac

“FDA” recommends the withdrawal of ranitidine products from the market, chiefly Zantac

The US Food and Drug Administration recommended FDA Today, withdrawing all products containing ranitidine (the most famous of which is Zantac) is permanently withdrawn from the market and their residues from pharmacies immediately and prevent their circulation or manufacture, due to research confirming that they contain impurities that are possibly carcinogenic.


Brent Screen of news

The organization said that the impurities are not caused by manufacturing, and that they increase in products, either with the passage of time or with a rise in temperature above room temperature, and therefore may lead to exposing the consumer to unacceptable levels of these impurities..

It recommended that it be withdrawn permanently, and that it should be suspended OTC That is, from the pharmacy without prescription, stop it for patients who persist in it and use alternatives available for the same purpose, such as famotidine / isomeprazole / lansoprazole / omeprazole.

It is worth noting that ranitidine was used to treat acidity and stomach ulcers.

This is the last step in the ongoing investigation of a pollutant known as N-Nitrosodimethylamine (NDMA) In ranitidine drugs (known as the brand Zantac).

The agency determined that impurities in some ranitidine products increase over time and when stored at temperatures above the room and may lead to consumer exposure to unacceptable levels of these impurities.

– .

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.